Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: A Taiwanese nationwide study

Chou H.-W.Wang J.-L.CHIA-HSUIN CHANGCHAO LUN LAILai M.-S.KIN-WEI CHAN2020-10-152020-10-1520151058-4838https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922345621&doi=10.1093%2fcid%2fciu914&partnerID=40&md5=d1102890bd8c6e01e945a78035940bd8https://scholars.lib.ntu.edu.tw/handle/123456789/517132Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: A Taiwanese nationwide studyjournal article10.1093/cid/ciu914254094762-s2.0-84922345621